Molecular Pathopharmacology of 5-HT2C Receptors and the RNA Editing in the Brain
-
- Tohda Michihisa
- Institute of Natural Medicine, University of Toyama, Japan
-
- Nomura Michio
- Department of Psychology, Tokai Women’s University, Japan
-
- Nomura Yasuyuki
- Yokohama College of Pharmacy, Japan
この論文をさがす
抄録
Among the 14 kinds of serotonin (5-hydroxytryptamine, 5-HT) receptor subtypes (5-HTR), 5-HT2C receptor (5-HT2CR) has been intensively investigated because of its physiologically and pathophysiologically important role in the brain. 5-HT2CR has been suggested to be involved in depressive disorders based on findings from pharmacological/neurochemical/behavioral studies using autopsy preparations of humans suffering from depression, animal models of depression, and animals treated with antidepressant drugs. Recently the editing of 5-HT2CR mRNA has been reported to participate in the pathogenesis of depressive disease. The RNA editing of 5-HT2CR induced by the presumable alteration of deaminase during a pathological state in depression causes changes of a base to another base (e.g., adenosine to guanosine, cytidine to uracil (thymidine)), followed by changes in amino acids constituting the second intracellular transmembrane loop that couples G proteins. Thus 5-HT2CR receptor-mediated signal transduction is changed. In the present review, the pathopharmacological significance of 5-HT2CR in special reference to RNA editing of receptors is reviewed and discussed from the aspect of development of novel therapeutics for depression.<br>
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 100 (5), 427-432, 2006
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680153798912
-
- NII論文ID
- 10018238768
-
- NII書誌ID
- AA11806667
-
- COI
- 1:STN:280:DC%2BD28zot1amuw%3D%3D
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 7963191
-
- PubMed
- 16799258
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可